| P50 | author | Wolf-Dieter Heiss | Q8029775 |
| | Uwe Pietrzyk | Q54181838 |
| | J Kessler | Q67216136 |
| P2093 | author name string | H Kugel | |
| | W Heindel | |
| | R Mielke | |
| | H H Schopphoff | |
| P2860 | cites work | In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease | Q48280375 |
| | Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy | Q48386144 |
| | Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. | Q48444633 |
| | Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro | Q48459459 |
| | Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain | Q48509796 |
| | Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study | Q48577021 |
| | In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes | Q48658012 |
| | N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues | Q48800486 |
| | Elimination of artifacts in short echo time H MR spectroscopy of the frontal lobe | Q48931220 |
| | HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. | Q53203336 |
| | “Mini-mental state” | Q25938989 |
| | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| | Evidence for a membrane defect in Alzheimer disease brain | Q28343061 |
| | Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? | Q30999665 |
| | A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline | Q31033036 |
| | Spatial localization in NMR spectroscopy in vivo | Q36448283 |
| | Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease | Q36708984 |
| | BrainN-acetyl-l-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study | Q41008278 |
| | N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study | Q41090089 |
| | Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease. | Q41443934 |
| | Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain | Q41456738 |
| | Severity of vascular dementia is related to volume of metabolically impaired tissue | Q45238509 |
| | Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease | Q45289669 |
| | Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging | Q48093916 |
| P433 | issue | 3-4 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 233-245 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | International Journal of Neuroscience | Q6051511 |
| P1476 | title | Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease | |
| P478 | volume | 107 | |